Surrozen, Inc. Common Stock (SRZN) Stock
Fundamentals
Source: third-party data provider, as of October 14, 2026
Compare with SRZN
Recent news

MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
SRZN

Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
SRZN

Huge Insider Buying in Media by Warren Buffet and More
Huge Insider Buying in Media by Warren Buffet and More
SRZN

5 Top Stocks Likely to Come Up With Earnings Beat
5 Top Stocks Likely to Come Up With Earnings Beat
SRZN
Technical indicators
- RSI 14
- 46.66
- MACD 12/26/9
- 1.17
- EMA 9 of MACD
- 1.57
- MACD histogram
- -0.39
- SMA 50
- $23.61
- Price below SMA 50
- EMA 50
- $24.30
- Price below EMA 50
- SMA 200
- $24.71
- Price below SMA 200
- EMA 200
- $23.19
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
Source: third-party data provider
Latest news

MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
SRZN

Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
SRZN

Huge Insider Buying in Media by Warren Buffet and More
Huge Insider Buying in Media by Warren Buffet and More
SRZN

5 Top Stocks Likely to Come Up With Earnings Beat
5 Top Stocks Likely to Come Up With Earnings Beat
SRZN

Penny Stocks To Buy? 4 Cheap Stocks To Watch Right Now
Penny Stocks To Buy? 4 Cheap Stocks To Watch Right Now
SRZN
About Surrozen, Inc. Common Stock
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Craig C. Parker M.B.A. | CEO, President & Director | 1962 |
| Mr. Charles Williams | COO & Corporate Secretary | 1980 |
| Mr. Andrew Maleki | Chief Financial Officer | 1990 |
| Dr. Yang Li Ph.D. | Executive Vice President of Research | 1969 |
| Dr. K. Christopher Garcia Ph.D. | Co-Founder & Member of Scientific Advisory Board | — |
| Dr. Roeland Nusse Ph.D. | Co-Founder & Member of Scientific Advisory Board | 1950 |
| Dr. Calvin Kuo M.D., Ph.D. | Co-Founder & Member of Scientific Advisor | — |
| Dr. Daniel L. Chao M.D., Ph.D. | VP & Head of Clinical Development | — |
| Mr. Michael Lauw M.S.W. | Senior Vice President of Development Operations | — |
| Esther Jhun | Controller | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 14, 2026
Technical indicators
- RSI 14
- 46.66
- MACD 12/26/9
- 1.17
- EMA 9 of MACD
- 1.57
- MACD histogram
- -0.39
- SMA 50
- $23.61
- Price below SMA 50
- EMA 50
- $24.30
- Price below EMA 50
- SMA 200
- $24.71
- Price below SMA 200
- EMA 200
- $23.19
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $54.00
- Average
- $54.00
- High
- $54.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +94.7 | -21.6 |



